PepTalk – ALLU

KNOW YOUR PRODUCT

The important details, first.

RECONSTITUTION

Vial size + diluent

Vial size	Diluent / amount	Final concentration
10 mL pre-mixed	No reconstitution required	Ready-to-use solution

QUICK REFERENCE

Frequency, site, cycle, and timing

Item	Guidance	Notes
Dose reference	1.25 mg	As documented in the dosing guide.
Frequency	2–3× weekly	Morning.
Duration	8–12 weeks	Protocol duration.
Route	Intramuscular or subcutaneous	Protocol route.

DOSING + ADMINISTRATION

ALLU protocol reference

Phase / week	Dose	Frequency	Administration / U-100 draw
Weeks 1–2	0.25 mL	2–3× weekly	25 units (0.25 mL).
Weeks 3–4	0.50 mL	2–3× weekly	50 units (0.50 mL).
Weeks 5–6	0.75 mL	2–3× weekly	75 units (0.75 mL).
Weeks 7–8	1 mL	2–3× weekly	100 units (1.00 mL).
Weeks 9–12 · optional	1 mL	2–3× weekly	100 units (1.00 mL).

Administration syringe: U-100 insulin syringe units shown in this table apply to drawing and administering the prepared dose only. Do not use these unit markings to determine the bacteriostatic-water amount for reconstitution.

MEASURING GUIDE

Volume and syringe conversion

Reference	Volume	Equivalent
1 unit	0.01 mL	0.05 mg

VIALS NEEDED

Protocol planning

Duration	Vials needed
8 weeks	1–2 vials
12 weeks	2–3 vials

Vial counts are calculated from the dosing schedule shown above and rounded up to whole vials. They are planning estimates and do not include extra allowance for wastage.

STORAGE

How to keep it correctly.

Storage item	Direction	Notes
Storage	Room temperature	Keep away from direct heat and light.

ADMINISTRATION

Where, when, and how.

Item	Guidance	Notes
Route	Intramuscular or subcutaneous	Protocol route.
Timing	Morning	2–3× weekly.
Syringe	U-100 insulin syringe	1 unit = 0.01 mL = 0.05 mg as documented.

Do not guess syringe units.

Syringe units measure volume, not milligrams. The correct draw amount changes when the vial strength or reconstitution volume changes.

06

SAFETY

Know when not to guess.

Talk to a doctor first when...

You have an existing medical condition or take regular medication.
You are pregnant, breastfeeding, trying to conceive, or unsure about suitability.
You have a history of significant allergic reactions or product-specific contraindications.
You are considering combining products or changing your dose.

PERSONAL GUIDANCE

Want someone to guide you through it?

ALLU can connect you with a doctor for a paid consultation focused on your health history, medications, goals, concerns, and questions.

Talk to a Doctor

07

FAQ + RESEARCH

Only the questions that help.

Where does PepTalk information come from?+

ALLU organizes product reference material, available research, and safety information into one easier-to-read guide. Information should be verified against the specific product and current evidence before being used as personal medical guidance.

What if my question is not answered here?+

For product or order questions, contact ALLU support. For personal medical questions, suitability, symptoms, interactions, or dose decisions, use the doctor consultation option.

Can I copy someone else's protocol?+

No. A protocol that suits another person may not be appropriate for you, and vial strengths or preparation methods can differ. Use information that matches your exact product and seek individualized guidance when needed.

Research & references+

PepTalk is designed to separate established clinical information from research-stage or community information. The full reference layer will be added as each product guide is validated.